Explore the latest in hepatitis B, including recent advances in diagnosis and antiviral treatment, prevention of complications, and more.
This cross-sectional study of health claims from patients with private insurance examines trends in the cost of entecavir prescribed for chronic hepatitis B treatment.
A 27-year-old woman presented with elevated transaminase levels and a positive hepatitis B surface antigen test result. How do you interpret these test results?
This randomized clinical trial examines the manufacturing equivalence of a 3-antigen hepatitis B virus (HBV) vaccine and evaluates the noninferiority of its seroprotection rate vs a single-antigen HBV vaccine.
This randomized clinical trial compares the standard hepatitis B virus (HBV) revaccination schedule for patients with HIV vs a regimen with higher doses.
This case-control study examines the association between hepatitis B flare and exposure to Bcr-Abl tyrosine kinase inhibitors (TKIs) compared with non–Bcr-Abl TKIs.
This cohort study examines the trends of hepatocellular carcinoma (HCC) incidence rates and compares rates by risk factors among people in the US and Canada with HIV infection in the combination antiretroviral therapy era.
This JAMA Patient Page reviews the US Preventive Services Task Force’s 2020 recommendation to screen for hepatitis B infection in adolescents and adults at increased risk (B recommendation).
This systematic review to support the 2020 US Preventive Services Task Force Recommendation Statement on screening for hepatitis B virus infection summarizes published evidence on the benefits and harms of screening and interventions for hepatitis B infection in nonpregnant adolescents and adults.
This 2020 US Preventive Services Task Force Recommendation Statement recommends screening for HBV infection in adolescents and adults at increased risk for infection (B recommendation).
This cohort study uses data from the electronic health records of Kaiser Permanente Southern California members to assess whether the number of doses in a hepatitis B virus vaccine series is associated with completion of the series among US adults.
This cross-sectional study used NHANES data from 1999 to 2016 to assess the trends in self-reported hepatitis B vaccination coverage and serologic evidence of immunity among children and adolescents in the US.
This survey study evaluates adult Medicaid beneficiaries’ access to adult immunization services through review of vaccination benefits coverage in Medicaid programs across the 50 states and the District of Columbia.
This prognostic study evaluates the feasibility and availability of a novel hepatitis B virus DNA index to assess the prognosis of patients with hepatitis B virus–related hepatocellular carcinoma.
This cross-sectional study compares the prevalence of diagnosis with chronic hepatitis B infection from a large database of privately insured patients with the prevalence of infection found in the National Health and Nutrition Examination Survey to estimate the prevalence of undiagnosed chronic hepatitis B in the US.
Customize your JAMA Network experience by selecting one or more topics from the list below.